➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
Merck
Express Scripts
Mallinckrodt

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Litigation Details for SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD.
The small molecule drug covered by the patents cited in this case is   Get Started for $10 .

Details for SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-01-30 1 United States Patent No. 8,129,431 (“the ’431 patent”), arising under the United States patent laws, Title… COUNT FOR PATENT INFRINGEMENT 11. The U.S. Patent and Trademark Office …Office (“PTO”) issued the ’431 patent on March 6, 2012. The ’431 patent claims, inter alia, formulations of…Senju is the assignee of the ’431 patent. A copy of the ’431 patent is attached hereto as Exhibit A. …. COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Senju Pharmaceutical External link to document
2015-11-17 107 the various patents covering Plaintiffs’ Prolensa® product: U.S. Patent Nos. 8,129,431 (“the ’431…of U.S. Patent No. 8,129,431, IPR2015-00903 (Innopharma); Inter Partes Review of U.S. Patent No. 8,754,131… The patents at issue in this case, namely, the ’431 patent, the ’290 patent, the ’131 patent, the …431 patent”), 8,669,290 (“the ’290 patent”), 8,754,131 (“the ’131 patent”), 8,871,813 (“the ’813 patent…patent”), and 8,927,606 (“the ’606 patent”) (collectively, the “patents- in-suit”). Before the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Express Scripts
Mallinckrodt
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.